These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25369038)

  • 21. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.
    Fransen van de Putte D; Blom R; van Soest H; Mundt M; Verveer C; Arends J; de Knegt RE; Mauser-Bunschoten E; van Erpecum K
    Ann Hepatol; 2011; 10(4):469-76. PubMed ID: 21911887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.
    Macías J; Camacho A; Von Wichmann MA; López-Cortés LF; Ortega E; Tural C; Ríos MJ; Merino D; Téllez F; Márquez M; Mancebo M; Pineda JA
    AIDS; 2013 Oct; 27(16):2541-9. PubMed ID: 23736148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
    Chen Yi Mei SLG; Thompson AJ; Christensen B; Cunningham G; McDonald L; Bell S; Iser D; Nguyen T; Desmond PV
    PLoS One; 2017; 12(10):e0185609. PubMed ID: 29065124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
    Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
    Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
    Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study.
    Sultanik P; Kramer L; Soudan D; Bouam S; Meritet JF; Vallet-Pichard A; Fontaine H; Bousquet L; Boueyre E; Corouge M; Sogni P; Pol S; Mallet V
    Aliment Pharmacol Ther; 2016 Sep; 44(5):505-13. PubMed ID: 27407002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.
    Isgro G; Calvaruso V; Andreana L; Luong TV; Garcovich M; Manousou P; Alibrandi A; Maimone S; Marelli L; Davies N; Patch D; Dhillon AP; Burroughs AK
    J Gastroenterol; 2013 Aug; 48(8):921-9. PubMed ID: 23124603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
    Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
    Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
    Chang PE; Hartono JL; Ngai YL; Dan YY; Lim KB; Chow WC
    Singapore Med J; 2019 Oct; 60(10):532-537. PubMed ID: 30556091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
    Shili-Masmoudi S; Sogni P; de Ledinghen V; Esterle L; Valantin MA; Poizot-Martin I; Simon A; Rosenthal E; Lacombe K; Pialoux G; Bouchaud O; Gervais-Hasenknoff A; Goujard C; Piroth L; Zucman D; Dominguez S; Raffi F; Alric L; Bani-Sadr F; Lascoux-Combe C; Garipuy D; Miailhes P; Vittecoq D; Duvivier C; Aumaître H; Neau D; Morlat P; Dabis F; Salmon D; Wittkop L;
    PLoS One; 2019; 14(1):e0211286. PubMed ID: 30682180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
    Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Medrano LM; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Saura-Montalbán J; Vázquez-Morón S; Ryan P; Resino S
    PLoS One; 2018; 13(5):e0197115. PubMed ID: 29742149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.
    Marcellin P; Ziol M; Bedossa P; Douvin C; Poupon R; de Lédinghen V; Beaugrand M
    Liver Int; 2009 Feb; 29(2):242-7. PubMed ID: 18637064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):e975-80. PubMed ID: 21535322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
    Han SH; Kim SU; Kim CO; Jeong SJ; Park JY; Choi JY; Kim DY; Ahn SH; Song YG; Han KH; Kim JM
    PLoS One; 2013; 8(1):e52720. PubMed ID: 23300987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
    D'Ambrosio R; Aghemo A; Fraquelli M; Rumi MG; Donato MF; Paradis V; Bedossa P; Colombo M
    J Hepatol; 2013 Aug; 59(2):251-6. PubMed ID: 23528378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
    Kim SU; Kim DY; Park JY; Lee JH; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Choi EH; Song KJ; Park YN; Han KH
    J Clin Gastroenterol; 2010 Jan; 44(1):66-71. PubMed ID: 19609218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
    Chan HL; Wong GL; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Wong VW
    J Viral Hepat; 2009 Jan; 16(1):36-44. PubMed ID: 18673426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.